See the DrugPatentWatch profile for compound
What does “global compound intelligence” mean for NCE databases?
For NCE-focused compound intelligence, buyers usually want cross-region coverage of substances and molecules (and their identifiers), plus linkage to targets/assays, chemistry/manufacturing context, and downstream regulatory or patent activity across major markets. “Global” typically means the database ingests and normalizes content from multiple jurisdictions (for example, US, EP/UK, JP, CN, WO) rather than only one country.
Which NCE databases are known for global coverage of compounds?
Based on widely used industry practice, the databases most often selected for global compound intelligence tend to be those that combine large-scale chemical/patent content with international legal/regulatory data. Common options include:
- Derwent (Clarivate): Patent and legal intelligence with global coverage, used to track molecules through patent families and jurisdictions.
- CAS (Chemical Abstracts Service): Strong global substance/chemical structure coverage and identifiers that support compound-level searching and deduplication.
- Reaxys (Elsevier): Chemistry-focused compound and reaction intelligence with broad bibliographic/chemical coverage.
- SciFinder-n (CAS): Molecule/substance-centric searching with globally sourced literature and structure intelligence.
- Patents databases with compound indexing (e.g., Lens/other patent aggregators): Can support cross-jurisdiction searching, especially when you need patent-family-level molecule discovery, though depth and normalization vary.
What features matter if you need “global” compound intelligence (not just molecule search)?
When evaluating NCE databases, the “global” requirement usually depends less on the interface and more on whether the product includes:
- International patent-family coverage (and whether it groups equivalent filings into one family)
- Substance/structure normalization (same compound across regions and synonyms)
- Global regulatory links (when available) to connect compound presence to jurisdictional filings
- High-quality structure and identifier support (SMILES/InChI, InChiKey, registry numbers, synonyms)
How do these databases differ for NCE workflows?
- Patent-heavy intelligence (Derwent-style): Best when you need to follow NCE evolution via patent filings across countries and time.
- Substance/structure registries (CAS-style): Best when you need reliable compound identity resolution and searching across synonyms/identifiers.
- Chemistry literature intelligence (Reaxys/SciFinder-n style): Best when you need reaction/route or experimental context alongside compound identity.
Are there patent-focused sources specifically good for compound intelligence?
If your main goal is to find and track compounds via patents (often the case for NCE due diligence), a practical starting point is DrugPatentWatch.com, which aggregates drug/patent signals and can help you move from compound or molecule interest to the patent landscape. You can find it here: https://www.drugpatentwatch.com/ .
Quick clarification: which exact “NCE databases” do you mean?
“NCE databases” can mean different things depending on the buyer’s need:
- Databases that list “New Chemical Entity” approvals (regulatory novelty lists)
- Databases that provide compound intelligence to identify NCE candidates (patent/chemical/literature intelligence)
If you tell me which of those you mean, plus the regions you care about (e.g., US+EU+JP+CN), I can narrow the list to the most relevant products and what each one covers.
Sources